The ability of cells to maintain genomic integrity is vital for cell survival and proliferation. Lack of fidelity in DNA replication and maintenance can result in deleterious mutations leading to cell death or, in multicellular organisms, cancer. The purpose of this review is to discuss the known signal transduction pathways that regulate cell cycle progression and the mechanisms cells employ to insure DNA stability in the face of genotoxic stress. In particular, we focus on mammalian cell cycle checkpoint functions, their role in maintaining DNA stability during the cell cycle following exposure to genotoxic agents, and the gene products that act in checkpoint function signal transduction cascades. Key transitions in the cell cycle are regulated by the activities of various protein kinase complexes composed of cyclin and cyclin-dependent kinase (Cdk) molecules. Surveillance control mechanisms that check to ensure proper completion of early events and cellular integrity before initiation of subsequent events in cell cycle progression are referred to as cell cycle checkpoints and can generate a transient delay that provides the cell more time to repair damage before progressing to the next phase of the cycle. A variety of cellular responses are elicited that function in checkpoint signaling to inhibit cyclin/Cdk activities. These responses include the p53-dependent and p53-independent induction of Cdk inhibitors and the p53-independent inhibitory phosphorylation of Cdk molecules themselves. Eliciting proper Gl, S, and G2 checkpoint responses to double-strand DNA breaks requires the function of the Ataxia telangiectasia mutated gene product. Several human heritable cancer-prone syndromes known to alter DNA stability have been found to have defects in checkpoint surveillance pathways. Exposures to several common sources of genotoxic stress, including oxidative stress, ionizing radiation, UV radiation, and the genotoxic compound benzo[alpyrene, elicit cell cycle checkpoint responses that show both similarities and differences in their molecular signaling. -Environ Health Perspect 107(Suppl 1):5-24 (1999 (Figure 1 ) (6, 8) .
the observation that cells increased in size from the completion of one cell division or mitosis (M phase) to the initiation of the next. The period between mitoses was termed interphase (3) . Later, DNA replication was found to occur at a discrete time during interphase, termed DNA synthesis phase or S phase (4, 5) . The period between mitosis and the subsequent S phase was termed Gap 1 (G1), while the period between S phase and the following mitosis was termed Gap 2 (G2). Thus the cell cycle was divided into four major phases (3, 6, 7) . Cells in a metabolically active state but not progressing to, or through DNA synthesis or cell division, were said to be quiescent or resting (Go). In the typical dividing eukaryotic cell, G, phase lasts approximately 12 hr, S phase 6 to 8 hr, G2 phase 3 to 6 hr, and mitosis about 30 min, although the exact length of each phase varies with cell type and growth conditions ( Figure 1 ) (6, 8) .
The description of the cell cycle being divided into four phases led to many questions about the regulatory mechanisms cells employ to ensure an ordered and sequential progression from G1 to M phase, as well as the mechanisms ensuring DNA stability. Some of these questions were summarized as the "completion" and "alternation" problems (8, 9 ). In the completion problem, the question is raised as to how cells ensure that specific events are completed before subsequent events are initiated. For example, cells must ensure that once DNA is condensed for segregation during cytokinesis, it remains condensed throughout M phase and does not prematurely decondense. In the alternation problem, the question is raised as to how cells ensure that once an event is completed, it is not inappropriately repeated. For example, cells must ensure that once DNA replication in S phase is completed, it is followed by DNA condensation and not by another round of replication.
Insight into the completion and alternation problems came from cell fusion experiments carried out by Rao and Johnson (10, 11) . When S phase cells were fused to and cellular integrity before initiation of subsequent events in cell cycle progression are referred to as cell cycle checkpoints and can cause a transient delay that has been suggested to allow the cell more time to repair damage before progressing to the next phase of the cycle [for reviews, see (12, 13) ]. Alternatively, if the damage is too severe to be adequately repaired, the cell may undergo apoptosis or enter an irreversible senescencelike state (13).
Molecular Biology of the Cell Cycle
The experiments by Rao and Johnson (10,11), although important, did not provide molecular information about the nature of SPF, MPF, or cell cycle checkpoint mechanisms. Since those initial observations, studies in budding and fission yeast, and frog and marine invertebrate oocytes and embryos, Drosophila embryos, and mammalian cells have led to the molecular characterization of SPF, and MPF, as well as a greater understanding of the molecular events that govern the cell cycle, the alternation/completion problems, and checkpoint function (8) . SPF and MPF have now been characterized as protein complexes whose key components consist of a regulatory protein subunit, referred to as a cyclin, and a protein kinase, called a cyclin-dependent kinase (Cdk).
Different cyclin/Cdk complexes are expressed in different phases of the cell cycle, with each cyclin having a specific time of appearance and kinase activity [for reviews, see (8, (14) (15) (16) ]. In this review we discuss the known cyclin/Cdk activities that characterize each phase of the cell cycle, the cellular signal transduction pathways of cell cycle checkpoints, and several genotoxic insults that can initiate checkpoint function. (8, 17, (21) (22) (23) . Cyclin D has a relatively short half-life (-20 min) and rapidly disappears with the removal of mitogenic stimuli or the addition of antiproliferative agents (17, 24, 25 [(17,21-25) ; for reviews, see (8, 32) ].
Three mammalian isoforms of cyclin D occur (types D1, D2, and D3 ) and each is differently expressed in different cell types (22, 23, 28, 33, 34 
S Phase Cydins
DNA replication occurs in a discrete portion of the cell cycle referred to as S phase (3, 6) . Expressed at low levels in G1, cyclin A protein levels steadily increase from S phase through G2, with degradation occurring during M phase (72, 73 
The S Phase Chekpoint
Less is known about the S phase checkpoint function than the G, and G2 checkpoint functions. Upon exposure to DNA-damaging agents, such as ionizing radiation, mammalian cells exhibit a dosedependent reduction in DNA synthesis within a few minutes (167-170). The suppression is biphasic, with a strong initial suppression at low doses of radiation and less additional suppression at higher dosages. The biphasic response has been attributed to a suppression of radiationsensitive new replicon initiation followed by the suppression of initiated replicons, the latter being less radiation sensitive (169,171). The suppression of replicon initiation is mediated by a trans-acting factor, as ionizing radiation inhibits both chromosomal replication and the replication of a resident autonomously replicating plasmid, even when the radiation dosage is not sufficient to damage the autonomously replicating plasmid (172). S phase cyclin A/Cdk2 activity, which is thought to be necessary for S phase progression (see previous discussion), is suppressed by treating cells with ionizing radiation. Interestingly, neither the inhibition of DNA synthesis nor the inhibition of cyclin A/Cdk2 activity is seen in cells from patients with AT (173). Thus, the AT gene product appears to be required for appropriate S phase checkpoint response to DNA damage.
The G2 Chekpoint
Ionizing radiation and other agents that trigger the G2 checkpoint response suppress cyclin B/Cdc2 kinase activation at the G2/M border (174,175). Treatment An additional component that likely contributes to the G2 checkpoint is regulation of the subcellular localization of cyclin B/Cdc2 protein complexes. Cyclin B/Cdc2 complexes accumulate in the cytoplasm in S/G2 phase and then as cells progress from G2->M, cyclin B/Cdc2 complexes move into the nucleus (94,95). Cyclin B complexes are retained in the cytoplasm in response to ionizing radiation treatment, suggesting that differential localization might also account for some aspects of the G2 checkpoint function (187) (188) (189) .
Another mechanism of suppression of cyclin B/Cdc2 protein kinase activity may involve the regulation of cyclin B levels. In S phase-irradiated cells, cyclin B mRNA and protein levels have been reported to be inhibited, whereas in G2-irradiated cells, cyclin B mRNA stability and promoter activity are suppressed (190) (191) (192) . It is important to note, however, that cyclin B downregulation has not been observed in other studies (176, (193) (194) (195) (196) (197) , and the importance of this level of regulation remains unclear.
The Cdk inhibitor p21 has been shown to associate with the cyclin B/Cdc2 complex. Cells in which the function of p53 has been disrupted either by expression of SV40 T-antigen or expression of the human papilloma virus type 16 E6 gene product (both of which bind andfunctionally inactivate p53, and hence prevent p53-dependent induction of p21 expression) have been found to have an accelerated G2 entry and higher cyclin A/B kinase activity (140, (198) (199) (200) (201) (202) . In fact, it has been suggested that p21 plays a role in the G2/M transition by inhibiting the activation of cyclin A/Cdk2 kinase complexes, thus delaying the activation of cyclin B/Cdc2 complexes in G2 and that this delay could contribute to G2 checkpoint function (140). However, normal human fibroblasts expressing the E6 protein for only a few population doublings show a normal initial G2 checkpoint response to ionizing radiation, suggesting that p21 is not required for the immediate G2 checkpoint in response to ionizing radiation (203) . Thus the role of p21 appears to be ancillary for the immediate early G2 checkpoint delay.
The Spindle Checkpoint
Most cells contain a spindle checkpoint that arrests cells in mitosis until all chromosomes are attached properly to the spindle [for reviews, see (204) (205) (206) ]. Much of our understanding of the genes and the gene products that make up the spindle checkpoint pathway comes from studies with budding yeast and frog eggs, in addition to studies with mammalian systems. The critical transition from metaphase to anaphase and the separation of sister chromatids is monitored by the spindle checkpoint gene products that include the Mad (mitotic arrest defective) proteins, Madl-3p, the Bub (budding uninhibited by benomyl) proteins, Bubl3p, and Mpsl (206) . To progress through this transition, cells must proteolytically degrade a number of proteins that are required earlier for entry into mitosis and this is accomplished by the activation of the proteasome, a component of the large multiprotein complex referred to as the anaphase-promoting complex or APC (207) (208) (209) . Ubiquitin conjugation and proteolysis by APC results in the degradation of cyclin B proteins and the inactivation of MPF that is necessary for exit from mitosis (210, 211) as well as the degradation of proteins involved in sister chromatid cohesion such as Pdslp (212, 213) and proteins involved in cross-linking spindle microtubules such as Aselp (214) . Agents such as nocodazole and colcemid arrest cells in a prometaphase state because of disruption of microtubule reorganization and spindle apparatus formation (215, 216 ). Anaphase will not begin until all the kinetochores receive bipolar spindle apparatus attachments (217) . Li and Nicklas (218) showed that an M phase block induced by an unattached chromosome in insect cells was relieved through the application of tension to the unattached chromosome. It was hypothesized that tension resulted in a change in kinetochore chemistry, relieving the M phase arrest. Furthermore DNA-damaging agents, in addition to spindle-damaging agents, can activate the spindle checkpoint surveillance mechanism and this signaling pathway seems to involve Cdc20 proteins that interact with the Mad proteins (219, 220) , Mecl proteins, which signal through Psdlp (213) , the Polo-like kinase Environmental Health Perspectives * Vol 107, Supplement 1 * February 1999 (Plk) proteins (221) (222) (223) (224) , and perhaps protein kinase A (PK A), which can regulate the activity of APC (225) . As with the other checkpoint functions, the spindle checkpoint is disrupted in tumor cells, with both a reduction in the levels of hsMAD2 observed in breast cancer cells (226) and mutationally inactive BUBI found in tumor cells displaying chromosomal instability (227) .
p53 and pRb were implicated as having roles in the spindle checkpoint response on the basis of the observation that cells lacking either function when cultured in the presence of spindle-damaging agents inappropriately initiate DNA synthesis without undergoing cytokinesis (228, 229) . However, recent evidence indicates that p53 and pRb probably do not function in this checkpoint (230, 231 (239) (240) (241) (242) (243) . For example, when baby hamster kidney cells synchronized at GI/S were treated with 0.5 pM nitrogen mustard, 90% survived. However, in the presence of 2 mM caffeine, the same treatment resulted in 5-to 10-fold greater lethality (244) . The molecular mechanism of caffeine's action remains unclear, but one of the consequences of the abrogation of the induction of the G1 delay following DNA damage is a failure to induce p53, and hence p21 (125). More recently caffeine has been found to inhibit the G2 checkpoint function by increasing Thr-14/Tyr-15 dephosphorylation on Cdc2 (197) . The finding that overriding the G, and G2 checkpoints results in lowered cell viability after damage supports the theory that one function of these checkpoints is to allow cells time to stop to repair damage before continuing the cell cycle. (267, (276) (277) (278) (279) (282) . The Rb gene is altered in a variety of human cancers, including breast, lung, and bladder cancers (283) (284) (285) (286) (287) (288) (289) . Relatives of Rb patients often have elevated cancer rates (290) .
Rb null mice die at day 14 to 16 in embryogenesis, exhibiting neuronal cell death and defective erythropoiesis (291) . Heterozygous mice with one defective Rb allele do not develop retinoblastomas but develop pituitary adenomas in which the wild-type Rb gene is lost (292, 293) . The Rb gene product appears to play a role in the maintenance of genomic stability (294, 295) . Both White et al. (294) and Reznikoff et al. (296) introduced human papilloma virus type 16 E6 proteins (which inactivate p53) and E7 proteins (which inactivate pRb) into isogenic human cells and, after extensive passaging, found that although the E6-transformed cells showed significant chromosomal abnormalities, the E7-transformed cells had minimal alterations. However, cells lacking functional pRb were found to amplify the dihydrofolate reductase gene when grown in the presence of methotrexate, indicating that loss of pRb function can contribute in some degree to genetic instability (294, 295) . These data, together with the data on germline Rb mutation, demonstrate that the Rb gene product plays a significant role in the maintenance of genomic integrity. Thymine-thymine dimers are the most common pyrimidine dimers formed following UV exposures, with cytosine-cytosine and cytosine-thymine dimers also occurring (330) . However, most UV-induced mutations occur at cytosines, suggesting that cells are able to replicate DNA through thymine dimer lesions without error (332, 333) . UV radiation also produces a number of less common DNA lesions such as the mutagenic 6-4 pyrimidine-pyrimidone dimers, thymine glycols, and protein-DNA crosslinking (330) . UV radiation also generates DNA damage indirectly via through the production of reactive oxygen species (ROS), including superoxide (0 -), the hydroxyl radical (OH), and hydrogen peroxide (H,02), all of which rapidly react with each other and surrounding biomolecules. In addition, exposure to UV radiation can cause multimerization, clustering, and activation of cell surface receptor proteins for growth factors and cytokines, with activation of receptor-associated tyrosine kinase activities (334 Exposure to UV radiation is associated with an increased skin cancer risk and premature aging of the skin, particularly among fair-skinned individuals with histories of being sunburned. A strong positive correlation also exists between skin cancer and proximity to the equator, indicating that higher UV doses to human populations result in higher incidences of skin cancer [for reviews, see (338) (339) (340) (341) (342) ]. Enhanced removal of LW-induced pyrimidine dimers lowers skin cancer rates in mice, indicating that unrepaired dimers cause cancer in mammalian skin (343) . Individuals with the heritable syndrome Xeroderma pigmentosum (XP) have impaired ability to remove DNA lesions induced by UV and consequentially are extremely sensitive to UV exposure, which results in an increased risk of developing skin cancers (344) (345) (346) (347) (348) (349) (350) (351) (352) (353) (354) (355) (356) (357) . Generation of mice deficient in XP genes have confirmed the important role these gene products play in protecting against UV-induced tumorigenesis (358) (359) (360) (362) (363) (364) (365) (366) (367) (368) [for review, see (369) ]. IR damages all components of the cell and is known to produce more than 100 distinct DNA adducts (365) . Data derived from studies on the survivors of the Hiroshima and Nagasaki bombings indicate that exposures to IR resulted in an increased cancer incidence over that in unexposed populations, with increases observed in incidences of leukemia, and breast, stomach, colon, and lung cancers (370) . These studies also demonstrated that prenatal exposure to IR can also cause mental retardation and microcephaly (371, 372) .
IR damages DNA through direct and indirect mechanisms. Direct damage to DNA occurs as a result of the interaction of radiation energy with DNA. This can result in the generation of a variety of lesions, including the generation of abasic deoxyribose sites in DNA that are produced as a consequence of destabilization of the N-glycosidic bond, generation of ssDNA breaks and generation of dsDNA breaks. Indirect DNA damage comes from the interaction of DNA with reactive species formed by IR (367, (373) (374) (375) . Water is the predominant cellular constituent and more than 80% of the energy in IR deposited in cells results in the ejection of electrons from water (376, 377 373,395,396) . The number of different DNA modifications that 'OH is capable of producing appears to be over 100 (365) . 'OH has been implicated in the etiology of human cancers such as breast cancer and leukemia (397, 398) . In addition to being produced from endogenous sources, 'OH can be generated in the human body after exposures to a variety of exogenous substances including cigarette tars, dietary components high in fat and low in plant fiber, ethyl alcohol, asbestos fibers, and IR (365, (399) (400) (401) (402) Like H202-induced damage, much of the 2 -found within cells is produced from the mitochondrial electron transport chain (407) . 02-is detoxified by conversion to H202 through the action of superoxide dismutase, which in turn is converted into H20 + 02 by the action of catalyze (404) (332, (437) (438) (439) (440) (441) .
It is important to note that there are many other classes of environmental agents known to modify DNA and to be potent carcinogens. Included among these agents are aflatoxin and the aromatic and heterocyclic amines. Aflatoxin is a potent hepatocarcinogen produced by fungal contamination of foods and readily forms DNA adducts (442) . The heterocyclic and aromatic amines also readily form DNA adducts and have widespread industrial uses and occur in foodstuffs, cooked meat, and tobacco smoke (443, 444) . Although the effects of these and other important environmental mutagenic toxins upon cell cycle checkpoint function are as yet poorly understood, their ability to induce mutations in critical cell cycle regulatory genes, as has been demonstrated in the case of aflatoxin-induced mutations of p53 (445) , could seriously compromise checkpoint function.
DNA Repair Ability and Cancer Risk
The importance of DNA repair in maintaining genomic integrity and protecting against development of cancers has been shown in studies involving cancer patients and cancer-prone individuals as well as in studies involving genetically altered mice that exhibit deficiencies in DNA repair.
The connection between DNA repair defects and human cancer predisposition was first recognized by Cleaver (344, 345) (446, 447) . The BRCA1 and BRCA2 gene products, which when mutated predispose individuals to development of breast cancer, have been reported to play a role of in DNA repair and cell cycle checkpoint function (448) (449) (450) (451) (452) (453) (454) (455) (456) (457) . Defects in DNA repair, specifically in mismatch repair pathways, are important in the development of a variety of human cancers including cervixuterine cancer, lung cancer, head and neck cancers, colorectal cancer, and basal cell carcinoma (458) (459) (460) (461) (462) (463) (464) (465) (466) (467) (468) (469) (470) (471) (472) (473) . The postreplication DNA mismatch repair system recognizes and removes inappropriately paired nucleotides that may have been generated by DNA replication errors, errors generated in DNA recombination events, or base damage following exposures to genotoxic agents (465, 474, 475) . Mutations in DNA mismatch repair pathwavs have been reported to affect cell cycle checkpoint function, with the best evidence to date demonstrating an important role of the MLHl gene product in a p53-independent G, checkpoint response to DNA damage generated by 6-thioguanine, MNNG, and IR exposures (227, 419, 476, 477) . Furthermore, mice deficient in DNA mismatch repair have increased susceptibility to development of neoplasia (478) (479) (480) (481) .
Summary
Neoplastic progression has been demonstrated to involve increasing genetic instability (201, 470, (482) (483) (484) (485) (486) (487) (488) . The information gained from studies of the molecular mechanisms governing cell cycle control, DNA repair, and cell cycle checkpoint signaling in normal individuals and in individuals with heritable cancer syndromes, together with the effects of genotoxic substances on these biochemical pathways, demonstrates the importance of these molecular pathways in the maintenance of Environmental Health Perspectives * Vol 07, Supplement * February 999 genomic integrity. Loss of any aspect of these systems dramatically lessens DNA stability and cell viability and increases cancer susceptibility.
In particular, attenuation or ablation of cell cycle checkpoint signaling pathways results in a dramatic lessening of DNA stability in the face of genomic stress as well as lowered cellular viability and increased cancer susceptibility. These effects are particularly clear in studies involving caffeineinduced "checkpoint function over-ride" after DNA damage [for example (244) (490) .
The current model of the cell cycle checkpoint signaling in response to cellular damage and the generation of DNA strand breaks that result in both the G, and G2 checkpoint delays involves activation of the ATM protein, which leads to both p53 and Chkl activation. p53 initiates p21 transcription and the inhibition of cyclin/Cdk activity. Chkl activation results presumably in altered CDC25 phosphatase localization, and hence lack of activation of cyclin/Cdk protein kinase complexes. Although less is known about the S phase checkpoint function, signaling through this pathway is known to be ATM-dependent and involves cyclin/Cdk inhibition and the suppression of DNA synthesis.
Together the above data indicate that cell cycle checkpoint responses a) are active signaling pathways dependent upon a number of different gene products, b) play a vital role in maintaining genomic stability, c) generate a transient delay in the progression through the cell cycle, d) may be either wholly or partially ablated by the loss/mutation of a single gene such as ATM or p53, and e) may be initiated by a wide variety of genotoxic agents that may exert very different effects on the cell. Our increasing understanding of cell cycle checkpoint signaling pathways may help in the design of more efflcacious therapeutic strategies for treatment of cancers and other diseases that develop as a consequence of exposures to environmental genotoxins. Furthermore, understanding the role of cell cycle checkpoint responses to environmental exposures promises to aid in the development of more efficacious approaches to disease prevention. Such insight will provide us with a better understanding of the risks associated with exposures for the general population. Moreover, such data may allow more accurate assessment of risk for specific subpopulations of individuals predisposed to development of certain diseases because of genetic susceptibilities. Appropriate measures then can be designed to minimize those exposures associated with significant risks. 
